Immunotherapies that use combination approaches are now emerging. Recent research from University College London demonstrated how engineered immune cells called gamma-delta T-cells could act as ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

targeting metastatic clear cell renal cell carcinoma, marking a significant step in utilizing gamma delta CAR T cell therapies for solid tumors. The company also began dosing a lupus nephritis patient ...

Pan Am — the airline considered to be among the best of the world during travel’s so-called Golden Age — reportedly at one ...

IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program ACE1831 is an allogeneic gamma delta T cell therapy ...

Here is a breakdown of the information In8bio, Inc. presented to its investors. IN8bio, Inc. is a clinical-stage biopharmaceutical company specializing in gamma-delta T cell-based immunotherapies for ...

My doctor didn’t explain all the risks of my surgery, and I ended up with complications that I wasn’t prepared for. What can ...

Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology Association Congress and received FDA guidance for a future ...

In the world of cell therapy, Silicon Valley has long recognized that technological innovation is the key to solving ...

Plenary Oral Presentation at SNO will provide latest clinical trial results from the previously enrolled INB-200 studies of ...